LDA analysis for Study ST003417

(Analysis AN005616 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample source:BT-474 Breast cancer cells | Drug Treatment:1 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Drug Treatment:1 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Drug Treatment:200 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Drug Treatment:200 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Drug Treatment:20 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Drug Treatment:20 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Drug Treatment:500 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Drug Treatment:500 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Drug Treatment:50 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Drug Treatment:50 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Drug Treatment:5 uM TVB-2640
Sample source:BT-474 Breast cancer cells | Drug Treatment:5 uM TVB-3166
Sample source:BT-474 Breast cancer cells | Drug Treatment:Control

OR

Perform LDA on individual factors (all analyses in study)
  logo